Andrea DeCensi

Research interests

Publications

• Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial Neoplasia

  Journal of Clinical Oncology · 2019 · https://doi.org/10.1200/jco.18.01779

• Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis

  Cancer Cell · 2019 · https://doi.org/10.1016/j.ccell.2019.03.007

• Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update

  Journal of Clinical Oncology · 2019 · https://doi.org/10.1200/jco.19.01472

• Repurposing metformin for the prevention of cancer and cancer recurrence

  Diabetologia · 2017 · https://doi.org/10.1007/s00125-017-4372-6

• Metformin and Cancer Risk and Mortality: A Systematic Review and Meta-analysis Taking into Account Biases and Confounders

  Cancer Prevention Research · 2014 · https://doi.org/10.1158/1940-6207.capr-13-0424

• Use of Pharmacologic Interventions for Breast Cancer Risk Reduction: American Society of Clinical Oncology Clinical Practice Guideline

  Journal of Clinical Oncology · 2013 · https://doi.org/10.1200/jco.2013.49.3122

• Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data

  The Lancet · 2013 · https://doi.org/10.1016/s0140-6736(13)60140-3

• Dual Effect of Metformin on Breast Cancer Proliferation in a Randomized Presurgical Trial

  Journal of Clinical Oncology · 2012 · https://doi.org/10.1200/jco.2011.39.3769

• Preventive therapy for breast cancer: a consensus statement

  The Lancet Oncology · 2011 · https://doi.org/10.1016/s1470-2045(11)70030-4

• Duration of Chemotherapy for Metastatic Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

  Journal of Clinical Oncology · 2011 · https://doi.org/10.1200/jco.2010.31.5374

• Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis

  Cancer Prevention Research · 2010 · https://doi.org/10.1158/1940-6207.capr-10-0157

• Tamoxifen for the Prevention of Breast Cancer: Late Results of the Italian Randomized Tamoxifen Prevention Trial Among Women With Hysterectomy

  JNCI Journal of the National Cancer Institute · 2007 · https://doi.org/10.1093/jnci/djk154

• Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer

  Annals of Oncology · 2006 · https://doi.org/10.1093/annonc/mdl047

• Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial

  BMJ · 2005 · https://doi.org/10.1136/bmj.38391.663287.e0

• Tamoxifen and Metabolite Concentrations in Serum and Breast Cancer Tissue during Three Dose Regimens in a Randomized Preoperative Trial

  Clinical Cancer Research · 2004 · https://doi.org/10.1158/1078-0432.ccr-03-0538

• A Randomized Trial of Low-Dose Tamoxifen on Breast Cancer Proliferation and Blood Estrogenic Biomarkers

  JNCI Journal of the National Cancer Institute · 2003 · https://doi.org/10.1093/jnci/95.11.779

• Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma.

  PubMed · 2003

• Randomized Trial of Fenretinide to Prevent Second Breast Malignancy in Women With Early Breast Cancer

  JNCI Journal of the National Cancer Institute · 1999 · https://doi.org/10.1093/jnci/91.21.1847

• Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation.

  PubMed · 1995

Current projects

No projects listed.